Alpha-1 antitrypsin phenotypes in patients with lung, prostate and breast cancer

Saudi Medical Journal

Volumn 25, Issue 2, 2004, Pages 186-189

  El Akawi, Zeyad J ^a   Al Hindawi, Fatin K ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PATIENT; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; ISOELECTRIC FOCUSING; JORDAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPIC VARIATION; PREVALENCE; PROSTATE CANCER; STATISTICAL SIGNIFICANCE;

ALPHA 1-ANTITRYPSIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; JORDAN; LUNG NEOPLASMS; MALE; PHENOTYPE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 1442351219     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Robin WC, Jan-Olef J, Carl-Bertil L, Stephen OB, Maurice CO, Lloyd V et al. Structure and variation of human alpha-1 antitrypsin. Nature 1982; 298: 329-333.
2. Ronald GC, Mark LB, Richard CH, David TC, David JS, Mark DH. The alpha-1 antitrypsin gene and its mutations. Chest 1989; 95: 196-208.
3. Coakley RJ, Taggart C, O'Neill S, Mc Elvane NG. Alpha-1 antitrypsin deficiency: biological answers to clinical questions. Am J Med Sci 2001; 321: 33-41.
4. Jeppsson JO, Franzen B. Typing of genetic variants of alpha-1 antitrypsin by electrofocusing. Clin Chem 1982; 28: 219-225.
5. Myron AJ. Genetic typing of alpha-1 antitrypsin by immunofixation electrophoresis: Identification of subtype M. J Lab Clin Med 1976; 87: 152-163.
6. Feld RD. Heterozygosity of alpha-1 antitrypsin: a health risk. Crit Rev Clin Lab Sci 1989; 27: 461-468.
7. Mordechaia R, Judith SG, Robert HK, Martin P, David HV. Lack of increase in heterozygous alpha-1 antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma. Hepatology 1992; 15: 407-410.
8. Pilacik B. Alpha-1 antitrypsin phenotypes and their role in medical diagnosis. Med Pr 1987; 38: 376-383.
9. Hui Z, Hans-peter F. Liver carcinoma in PiZ alpha-1 antitrypsin deficiency. Am J Surg Pathol 1998; 22: 742-748.
10. Seersholm N, Kok-Jensen A. Intermediate alpha-1 antitrypsin deficiency PISZ: a risk factor for pulmonary emphysema. Respir Medicine 1998; 92: 241-245.
11. Elzouki AN, Eriksson S. Risk of hepatobiliary disease in adults with severe alpha-1 antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1996; 8: 989-994.
12. Yang P, Wentzlaff KA, Katzmann JA, Marks RS, Allen MS, Lesnick TG et al. Alpah-1 antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemol Biomarkers Prev 1999; 8: 461-465.
13. Benkmann HG, Hanssen HP, Ovenbeck R, Goedde HW. Distribution of alpha-1 antitrypsin and haptoglobin phenotypes in bladder cancer patients. Hum Hered 1987; 37: 190-293.
14. Sizaret P, Clerc M, Esteve J, Frants RR, Pillot J. M2 alpha-1 antitrypsin phenotype and primary liver cancer. Br J Cancer 1981; 43: 226-228.
15. Lieberman J, Silton RM, Ahliozzo CM, Mc Mahon J. Hepatocellular carcinoma and intermediate alpha-1 antitrypsin deficiency (MZ phenotype). Am J Clin Pathol 1975; 64: 304-310.
16. Smanadhikorn P, Porgpaew P, Srivatonakul P, Tungtrogchitr R, Supanaranond W, Schelp FP et al. Alpha-1 antitrypsin phenotypes PiMZ, a risk factor for liver cirrhosis but not live cancers in Thailand. Southeast Asian J Trop Med Public Health 1995; 26: 240-242.
17. Garcia-Orad A, Arizti P, Duran L, Urcelay B, de Paneorbo MM. Alpha-1 antitrypsin phenotypes among breast cancer patients in the Basque population. Hum Hered 1994; 44: 203-208.
18. Labadie H, Sesbone R, Martin JP, Beaugrand M. Hepatocellular carcinoma and the alpha-1 antitrypsin phenotype. Gastroenterol Clin Biol 1985; 9: 881-885.
19. Lu Z, Feng B, Feng J, Chen R, Xu J, Du R. Studies of distribution of subtypes of transferrin, group-specific component, alpha-1 antitrypsin in gastric cancer from Shangahai area. Yi Chuan Xue Bao 1992; 19: 390-396.
20. John AP, Jan-Olaf J, Carl-Bertil L. Alpha-1 antitrypsin phenotypes determined by isoelectric focusing of the cysteine-antitrypsin mixed disulfide in serum. Anal Biochem 1976; 74: 227-241.
21. Sparos Y, Tountas L, Theodoropoulous C, Trichopoulos D. Alpha-1 antitrypsin and cancer of the pancreas. Digestion 1985; 31: 37-40.
22. Debrowska M, Mantur M, Panasiuk A, Prokopowicsz J. Does the concentration of alpha-1 proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma. Neoplasma 1997; 44: 305-307.
23. Zietek Z, Iwan-Zietek I, Kotschy M, Tyloch F. Activity of alpha-1 antitrypsin in blood of patients with prostatic tumor. Pol Tyg Lek 1996; 51: 89-90.
24. Harris CC, Cohen MH, Conner R, Primack A, Saccomanno G, Talamo RC. Serum alpha-1 antitrypsin in patients with lung cancer or abnormal sputum cytology. Cancer 1976; 38: 1655-1657.
25. Patenoster D, Cartei G, Campagnutta E, Maggino T, Valente S, Ongaro G. Acute reactive stage proteins in gynaecologic cancers. Eur J Gynaecol Oncol 1980; 1: 94-98.
26. Clerc M, Le Bras M, Loubiere R, Houvet D. Primary liver carcinoma: deficiency of alpha-1 antitrypsin. Nouv Presse Med 1977; 6: 3061-3064.
27. Elzouki AN, Eriksson S. Risk of hepatobiliary disease in adults with severe alpha-1 antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1996; 8: 989-994.
28. Zhou H, Hans-peter F. Liver carcinoma in PiZ alpha-1 antitrypsin deficiency. Am J Surgi Pathol 1998; 22: 742-748.
29. Zhou H, Ortiz-Pallardo ME, Ko Y, Fisher HP. Is heterozygous alpha-1 antitrypsin deficiency type PiZ a risk factor for primary liver carcinoma. Cancer 2000; 88: 2668-2676.
30. Hitzetoth HW, Bissbort S, Van den Berg CT, Van Niekerk MM, Op't Hof J. Alpha-1 antitrypsin genetic polymorphism in South Africa. S Afr Med J 1987; 71: 755-759.
31. Labadie H, Sesbone R, Martin JP, Beaugrand M. Hepatocellular carcinoma and the alpha-1 antitrypsin phenotype. Gastroenterol Clin Biol 1985; 9: 881-885.
32. Govindarajan S, Ashcavai M, Peters RL. Alpah-1 antitrypsin phenotypes in hepatocellular carcinoma. Hepatology 1981; 1: 628-631.